Is the U.S. Losing Measles Elimination Status? What It Means for Your Family

Published November 10, 2026

Public health data points over a map representing disease surveillance

This week, an independent expert commission convened by the Pan American Health Organization (PAHO) is meeting to review measles elimination across the Americas. PAHO has said the review will look closely at the United States and Mexico. You may see headlines asking whether the U.S. is about to "lose" its measles elimination status.

Here is what that status actually means, how the review works, and what would and wouldn't change for your family. The short version: no decision has been announced, and whatever the outcome, the steps that protect your family are the same.

Where things stand: The U.S. measles elimination status is under review. PAHO said in October 2026 that Canada is currently the only country in the Americas classified as endemic for measles, and all other countries retain their elimination status (PAHO). We will update this post only when PAHO or CDC publishes its own statement on the outcome.

What "measles elimination" means

Elimination does not mean zero measles cases. CDC defines measles elimination as the absence of endemic measles transmission for 12 months or more in the presence of a high-quality surveillance system (CDC, MMWR). Endemic transmission is a chain of measles spread that continues for 12 months or longer within the country (CDC surveillance manual).

In other words, a country with elimination status can still have measles cases and outbreaks, usually sparked when someone brings the virus in from abroad. What matters is whether any single chain of spread keeps going for a full year.

PAHO uses a specific, lab-based test for that. It says endemic transmission is re-established when epidemiological and laboratory evidence shows that a chain of transmission involving a virus with an identical genotype and lineage has continued uninterrupted for 12 months or longer in a country or defined area (PAHO). So the question is about the genetics of the virus and how it spread, not simply about how many cases there were.

The U.S. was declared measles-free (eliminated) in 2000 (CDC), and the Americas became the first WHO region verified as having eliminated measles in 2016 (CDC).

Who decides, and how the review works

The decision rests with the Measles and Rubella Elimination Regional Monitoring and Re-Verification Commission (RVC), an independent technical body of international experts in epidemiology, public health, virology, pediatrics and immunization. It advises PAHO's Director. Its sixth annual meeting runs November 10–13, 2026 (PAHO).

According to PAHO:

Every country is reviewed. All Member States submit national reports. PAHO said in March that the review of the United States and Mexico would take place at this November meeting, with particular focus on countries with active outbreaks and those that have completed one year of sustained transmission (PAHO, March 2, 2026).
The review window starts with each outbreak. For the U.S., PAHO set the analysis period as one year from the onset of the reported outbreaks, starting January 20, 2025. For Mexico it starts February 1, 2025 (PAHO). PAHO also noted that U.S. health authorities were doing complete viral genome sequencing as part of their analysis.
Many kinds of evidence count. The commission examines data for 2025 and the first half of 2026: vaccination coverage, the quality of disease surveillance, laboratory results (including molecular evidence), outbreak response, and immunization program performance. PAHO says no single source of evidence determines the outcome (PAHO).
Results come after the meeting. The meeting is closed. The commission sends its conclusions to PAHO's Director, who formally communicates each country's classification to national authorities. The commission later publishes a final report (PAHO). That means a public announcement may not come on the last day of the meeting.

Has this happened before?

Yes. In November 2025, the RVC concluded that endemic transmission had been re-established in Canada, where the virus had circulated uninterrupted for at least 12 months. Under PAHO's framework, that also meant the Americas as a whole lost its status as free of endemic measles (PAHO; CDC). Countries can also earn the status back: CDC notes that after the Americas was verified in 2016, endemic transmission was re-established in Venezuela and Brazil, and both were later re-verified (Venezuela in 2023 and Brazil in November 2024) (CDC, MMWR).

What a change would and wouldn't mean for your family

What wouldn't change

The virus and the vaccine are the same. A classification describes how measles has been spreading. It doesn't change how contagious measles is or how well the vaccine works. Two doses of MMR are about 97% effective at preventing measles, and one dose is about 93% effective (CDC).
MMR is still the protection. CDC's routine schedule is two doses for children, the first at 12–15 months and the second at 4–6 years, and at least one documented dose for most adults born in 1957 or later (CDC). A PAHO classification doesn't by itself change those recommendations. Any change to vaccine advice would come from CDC or your state health department, and we'd report it.
Your own risk depends mostly on your immunity and where you are. A fully vaccinated person's protection is the same the day after an announcement as the day before.

What it would signal

A change in how measles spreads here. Losing status would mean reviewers found that at least one chain of measles spread kept going in the U.S. for 12 months or more, rather than measles mostly arriving from abroad and then dying out.
More attention on vaccination gaps. PAHO says keeping elimination requires vaccination coverage of 95% or higher across communities, sensitive surveillance, strong lab capacity, and fast outbreak response (PAHO). CDC reports MMR coverage among U.S. kindergartners was 92.4% in the 2025–26 school year, below that 95% target (CDC).

The current numbers

Each agency counts on its own schedule and with its own definitions, so we list them separately. Death counts in particular should not be added together.

United States (CDC): 5,182 confirmed measles cases in 2026 as of November 5, reported by 47 jurisdictions (plus cases among international visitors). CDC counts 43 outbreaks this year, and 96% of cases (4,993 of 5,182) are outbreak-associated. CDC lists 4* deaths for 2026; the asterisk means the number is subject to change as reviews are completed. For all of 2025, CDC reported 2,289 confirmed cases (CDC). CDC updates weekly; figures are preliminary.
Pennsylvania (PA DOH): 1,487 confirmed cases across 45 counties as of November 6, 2026, with 287 hospitalizations and 6 confirmed measles-associated deaths under the state's definition (PA DOH).
Wisconsin (DHS): 477 confirmed cases as of November 6, 2026, with 9 hospitalizations and 1 death (Wisconsin DHS).

State counts are often more current than CDC's national page, and the two won't always match. Our outbreak map links to each state health department.

A death in Wisconsin

On November 5, 2026, the Wisconsin Department of Health Services reported the death of an infant associated with the ongoing measles outbreak in southwestern Wisconsin, the first such death reported in the state since 1990. DHS said the coroner listed measles as the immediate cause of death and that it would not release other details to protect the family's privacy (Wisconsin DHS). Our thoughts are with the family. Babies under 12 months are too young for the routine first MMR dose, which is why the immunity of the people around them matters so much.

Practical steps for your family

Check records. Look at your child's immunization card, school records, or your doctor's patient portal. Most states run an immunization registry that can look up past doses.
Catch up on missing doses. Children need two MMR doses. Most adults born in 1957 or later need at least one documented dose, and some groups (such as college students, health care workers, and international travelers) need two. See our adult MMR guide.
Ask about babies 6–11 months. CDC recommends an early MMR dose for infants 6 through 11 months before international travel. Pennsylvania also recommends an early "zero dose" for infants in counties its dashboard flags for sustained community transmission (PA DOH). The early dose doesn't replace the two routine doses. Read Early MMR Dose for Babies 6–11 Months and talk with your pediatrician.
Know what to do after an exposure. Call your doctor or health department before going in. See What to Do If You've Been Exposed to Measles.
Find a vaccine. MMR is usually no cost with most insurance, and health centers and local health departments often offer it at low or no cost if you're uninsured.

Need an MMR dose?

Our Find a Vaccine page lists pharmacies, community health centers, state immunization registries, and free or low-cost options through the Vaccines for Children program.

Find MMR Vaccines

Quick recap

Elimination means no chain of measles spread lasting 12 months or more, backed by good surveillance. It doesn't mean zero cases.
PAHO's independent commission is reviewing the U.S. and other countries November 10–13, 2026. The outcome hasn't been announced; we'll update from PAHO's or CDC's own statement.
Whatever the result, MMR is still the protection, and the vaccine works the same.
Check your family's records and catch up on any missing dose.

For background, see our March post, The U.S. Could Lose Its Measles Elimination Status (its figures are as of March 2026).

Sources

This article is for general informational purposes only and is not a substitute for professional medical advice. Always consult your physician, pediatrician, pharmacist, or local health department for medical decisions regarding your household.

Ready to check your vaccination options?

Find an MMR Vaccine Near You →